Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  Sinopharm Group Co., Ltd.    1099   CNE100000FN7

SINOPHARM GROUP CO., LTD.

(1099)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Alibaba's Cainiao says it is in talks with Chinese vaccine makers over logistics

12/03/2020 | 03:58am EST
Cainiao's logo, Alibaba's logistics unit, is seen at the warehouse in Wuxi

BEIJING/SHANGHAI (Reuters) - Alibaba Group's Cainiao is in talks with Chinese vaccine makers over COVID-19 vaccine logistics, a spokeswoman said on Thursday, as the company launched a partnership with Ethiopian Airlines to transport medicine to the Middle East and Africa.

"We are currently in discussion with some domestic COVID-19 vaccine manufacturers and international organizations on cooperation over COVID-19 vaccine logistics," the spokeswoman said.

Cainiao, a logistics company, underpins delivery for Alibaba's e-commerce marketplace, and it says it aims to deliver across the globe in 72 hours. The spokeswoman did not name the vaccine makers.

The company and Ethiopian Airlines launched a special cold chain air freight service to transport temperature-sensitive medicines from the southern Chinese city of Shenzhen to Africa and the rest of the world via Dubai and Addis Abba.

"This is China's first cross-border medical cold chain route to be operated regularly and is certified to transport temperature-controlled medicines including COVID-19 vaccines," Cainiao said in a statement.

China has several vaccine developers running the final stages of clinical trials to determine the efficacy of their COVID-19 vaccine candidates. They include Sinovac Biotech Ltd, CanSinoBio and China National Pharmaceutical Group (Sinopharm).

Cold chain storage and transportation have become increasingly important during the COVID-19 pandemic, which has killed nearly 1.5 million people. The promising Pfizer vaccine, for instance, is required to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below.

(Reporting by Roxanne Liu in Beijing and Brenda Goh in Shanghai. Editing by Gerry Doyle)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ALIBABA GROUP HOLDING LIMITED -0.53% 258.62 Delayed Quote.11.72%
CANSINO BIOLOGICS INC. -0.77% 258 End-of-day quote.46.18%
DOW JONES AFRICA TITANS 50 INDEX 0.26% 542.9 Delayed Quote.2.22%
PFIZER INC. 0.19% 36.55 Delayed Quote.-0.90%
S&P AFRICA 40 INDEX -0.60% 176.06 Delayed Quote.1.56%
SINOPHARM GROUP CO., LTD. 0.42% 19.14 End-of-day quote.1.48%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.-6.77%
All news about SINOPHARM GROUP CO., LTD.
01:14pWHO to consider two Chinese COVID-19 vaccines next week
RE
01/21India's vaccine diplomacy in south Asia pushes back against China
RE
01/21ANALYSIS : Surging cases strain UAE's open for business COVID strategy
RE
01/20World Health Organization Nears Emergency Approval for Three COVID-19 Vaccine..
MT
01/20SINOPHARM : Chinese COVID-19 Vaccine Makers Join WHO-backed COVAX Program
MT
01/20McKesson to replace some Moderna COVID-19 vaccines due to low temperature
RE
01/20WHO plans slew of COVID-19 vaccine approvals for global rollout
RE
01/20Three COVID-19 vaccines under final review for emergency use - WHO
RE
01/20WHO plans slew of COVID-19 vaccine approvals for global rollout - document
RE
01/20Who document says approval of chinese vaccines from sinopharm, sinovac possib..
RE
More news
Financials
Sales 2020 459 B 70 866 M 70 866 M
Net income 2020 6 851 M 1 057 M 1 057 M
Net Debt 2020 15 485 M 2 389 M 2 389 M
P/E ratio 2020 8,55x
Yield 2020 3,49%
Capitalization 59 652 M 7 695 M 9 204 M
EV / Sales 2020 0,16x
EV / Sales 2021 0,14x
Nbr of Employees 93 764
Free-Float 43,0%
Chart SINOPHARM GROUP CO., LTD.
Duration : Period :
Sinopharm Group Co., Ltd. Technical Analysis Chart | 1099 | CNE100000FN7 | MarketScreener
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Average target price 22,87 CNY
Last Close Price 19,14 CNY
Spread / Highest target 89,2%
Spread / Average Target 19,5%
Spread / Lowest Target -9,82%
EPS Revisions
Managers and Directors
NameTitle
Yong Liu President & Executive Director
Fang Yao Chairman-Supervisory Board
Qing Ming Yu Chairman
Xiu Chang Jiang Chief Financial Officer & Vice President
Jin Dong Deng Non-Executive Director
Sector and Competitors